N/A N=91 Enhanced SexHealth Intervention to Improve Adolescent Outcomes
Sexually Transmitted Diseases · Reproductive Behavior
Primary: Number of Participants With Uptake of 1 or More Health Services — 43; 33 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=63 Chronic Neuropathy Following Chemotherapy
Peripheral Nervous System Diseases · Chronic Pain
Primary: Chemotherapy-induced Peripheral Neuropathy — 21 participants
N/A N=136 mHealth Medication Safety Intervention
Medication Compliance
Primary: Number of Medication Errors — 9; 20 number of medication errors
N/A N=18 Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study
Copd · Smoking Cessation · Nicotine Dependence
Primary: Number of Participants Who Achieved 24-hour Smoking Abstinence at End-of-treatment — 1; 1; 2 Participants
Phase 1 N=104 A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Ascending, Subcutaneous, Single and Multiple Doses of SHP681 (Glucagon-like Peptide-2 [GLP-2] Analog-Fc Fusion) in Healthy Adult Participants
Healthy Volunteers
Primary: Number of Participants With Treatment-emergent Adverse Events (TEAEs), Serious TEAEs and TEAEs Based on Severity to SHP681 in Single Ascending Dose (SAD) — 3; 3; 2; 4…
N/A N=116 Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate Cancer
Prostate Cancer · Sexual Dysfunction · Sexuality and Reproductive Issues
Primary: Erectile Dysfunction Rates — 27; 36 Participants
N/A N=48 Effectiveness of a Online Training Program With a Clinical Procedure Standardized in Units of Nursing (CPSUN)
Infection Control · Preventive Measures
Primary: Number of Contaminated Cultures in the Control and Experimental Group Before Intervention and After the Learning Obtained With the Online Training Platform. — 17; 15; 5…
N/A N=12 TracelT Hydrogel in Localizing Bladder Tumors in Patients Undergoing Radiation Therapy for Bladder Cancer
Bladder Carcinoma
Primary: Changes in Interfraction Motion of the Marker Measured by Cone Beam Computed Tomography (CT) and x/y/z Coordinates — 0.62 cm
Phase 4 N=152 Safety of LAIV4 in Children With Asthma
Asthma in Children · Vaccine Adverse Reaction · Vaccine Reaction
Primary: Comparison of the Proportion of Participants Experiencing an Asthma Exacerbation During the 42 Days After LAIV4 vs. IIV4 (Until Day 43). — 8; 10; 66; 58 Participants
Phase 2 N=90 Myrcludex B in Combination With Peginterferon Alfa-2a Versus Peginterferon Alfa-2a Alone in Patients With Chronic Viral Hepatitis B With Delta-agent
Chronic Viral Hepatitis B With Delta-agent
Primary: Percentage of Patients With Negative HDV RNA by PCR — 0; 53.3; 26.7; 6.7 Percentage of participants — p=0.0022
Phase 2 N=55 Phase 1b/2 Safety and Efficacy of APR-246 w/Azacitidine for tx of TP53 Mutant Myeloid Neoplasms
Myelodysplastic Syndrome · Acute Myeloid Leukemia · Myeloproliferative Neoplasm
Primary: Phase 1b: Maximum Tolerated Dose (MTD) — 4500 mg/day
Phase 2 N=40 Comparison of Secukinumab Versus Guselkumab in Clearing Psoriatic Plaques Refractory to Ustekinumab
Chronic Plaque-type Psoriasis
Primary: Proportion of Subjects Whose Plaque Achieves "Clear" or "Almost Clear" Status (TCS = 0-2) — 12; 8 Participants — p=0.1715
N/A N=356 Genomics in Michigan Impacting Observation or Radiation
Prostate Cancer
Primary: Number of Participants That Receive Adjuvant Therapy (Radiation and/or Hormone Therapy) — 19; 12 Participants — p=0.27
N/A N=8 Study to Evaluate VORTX Rx (Theresa)
Carcinoma, Hepatocellular · Liver Metastases
Primary: Acute Technical Performance of the VORTX Rx® Medical Device for the Ablation of Primary and Metastatic Liver Tumors — 11 lesions
N/A N=242 Validating a New Method to Assess Estimated Blood Loss in the Obstetric Population
Pregnancy Complications
Primary: Clinical Estimated Blood Loss (EBL) Between Cases and Controls Using Clinical Estimate Versus Device Assessment — 800; 800 milliLiters